OOIR: Observatory of International Research

Papers

(The TQCC of Hypertension in Pregnancy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
A clinical and in-silico study exploring the association of CASP-3, NF-kB, miR-187, and miR-146 in pre-eclampsia	16
Risk of gestational hypertension and preeclampsia in pregnant women with new onset blood pressure of 120–129/≤89 mmHg: a meta-analysis of prospective studies	14
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial	13
Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China	12
Inflammasomes in placental explants of women with preeclampsia cultured with monosodium urate may be modulated by vitamin D	11
Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials	10
Blood pressure medication use and postpartum hospital readmission among preeclampsia patients	10
Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates	10
Pre-eclampsia screening with maternal risk factors and ophthalmic Doppler artery: a systematic review	9
Expression of Concern: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk	9
Intraabdominal pressure as a marker for physiologic and pathologic processes in pregnancy	9
WGCNA combined with machine learning for analysis of diagnostic markers of preeclampsia associated with the hedgehog signaling pathway	8
Statement of Retraction: Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section	8
Targeting oxidative stress in preeclampsia	7
Predictability of adverse outcomes in hypertensive disorders of pregnancy: a multicenter prospective cohort study	7
First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconceptio	6
Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy	6
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis	5
Use of the USCOM® noninvasive cardiac output measurement system to predict the development of pre-eclampsia in hypertensive pregnancies	5
Examining the relationship between maternal preeclampsia and autism spectrum disorder in childhood	5
Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy	5
Distinguishing preeclampsia using the falling scaled slope (FSS) --- a novel photoplethysmographic morphological parameter	4
The obesity associated FTO gene polymorphism and the risk of preeclampsia in Iranian women: A case–control study	4
Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study	4
Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?	4

Magnesium sulfate improves blood flow of uterine, umbilical, and fetal middle cerebral arteries in women with severe preeclampsia at 30-34 gestational weeks	3
MiR-140-5p exerts a protective function in pregnancy-induced hypertension via mediating TGF-β/Smad signaling pathway	3
Relationship between the hemodynamic profile and resistant hypertension in pregnant patients with hypertensive crisis	3
Urine and serum L-type fatty acid-binding protein levels in preeclampsia: a prospective cohort study on maternal deterioration prediction	3
Maternal and neonatal outcome among women with early-onset preeclampsia and late-onset preeclampsia	3
Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort	3
Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?	3
Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis	3